These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 2306790)
1. Physicochemical and pharmacokinetic parameters of seven lipophilic chlorambucil esters designed for brain penetration. Greig NH; Genka S; Daly EM; Sweeney DJ; Rapoport SI Cancer Chemother Pharmacol; 1990; 25(5):311-9. PubMed ID: 2306790 [TBL] [Abstract][Full Text] [Related]
2. Development of lipophilic anticancer agents for the treatment of brain tumors by the esterification of water-soluble chlorambucil. Genka S; Deutsch J; Shetty UH; Stahle PL; John V; Lieberburg IM; Ali-Osman F; Rapoport SI; Greig NH Clin Exp Metastasis; 1993 Mar; 11(2):131-40. PubMed ID: 8444006 [TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of chlorambucil-tertiary butyl ester, a lipophilic chlorambucil derivative that achieves and maintains high concentrations in brain. Greig NH; Daly EM; Sweeney DJ; Rapoport SI Cancer Chemother Pharmacol; 1990; 25(5):320-5. PubMed ID: 2306791 [TBL] [Abstract][Full Text] [Related]
4. The pharmacokinetics of prednimustine and chlorambucil in the rat. Newell DR; Shepherd CR; Harrap KR Cancer Chemother Pharmacol; 1981; 6(1):85-91. PubMed ID: 7273268 [TBL] [Abstract][Full Text] [Related]
5. Comparative brain and plasma pharmacokinetics and anticancer activities of chlorambucil and melphalan in the rat. Greig NH; Sweeney DJ; Rapoport SI Cancer Chemother Pharmacol; 1988; 21(1):1-8. PubMed ID: 3342460 [TBL] [Abstract][Full Text] [Related]
6. Cytotoxicity and metabolism of prednimustine, chlorambucil and prednisolone in a Chinese hamster cell line. Hartley-Asp B; Gunnarsson PO; Liljekvist J Cancer Chemother Pharmacol; 1986; 16(2):85-90. PubMed ID: 3948307 [TBL] [Abstract][Full Text] [Related]
7. Studies on the pharmacokinetics of chlorambucil and prednimustine in patients using a new high-performance liquid chromatographic assay. Oppitz MM; Musch E; Malek M; Rüb HP; von Unruh GE; Loos U; Mühlenbruch B Cancer Chemother Pharmacol; 1989; 23(4):208-12. PubMed ID: 2924378 [TBL] [Abstract][Full Text] [Related]
8. Lipophilicities of baclofen ester prodrugs correlate with affinities to the ATP-dependent efflux pump P-glycoprotein: relevance for their permeation across the blood-brain barrier? Leisen C; Langguth P; Herbert B; Dressler C; Koggel A; Spahn-Langguth H Pharm Res; 2003 May; 20(5):772-8. PubMed ID: 12751633 [TBL] [Abstract][Full Text] [Related]
9. To determine the cytotoxicity of chlorambucil and one of its nitro-derivatives, conjugated to prasterone and pregnenolone, towards eight human cancer cell-lines. Shervington LA; Smith N; Norman E; Ward T; Phillips R; Shervington A Eur J Med Chem; 2009 Jul; 44(7):2944-51. PubMed ID: 19121874 [TBL] [Abstract][Full Text] [Related]
10. Comparative pharmacokinetics of chlorambucil and prednimustine after oral administration. Loos U; Musch E; Malek M; Riedel E Oncology; 1991; 48(4):334-42. PubMed ID: 1891177 [TBL] [Abstract][Full Text] [Related]
11. Comparison of the cytotoxic effect of prednimustine in cultured cells with high or low levels of metallothionein. Endresen L Acta Pharmacol Toxicol (Copenh); 1984 Jan; 54(1):49-57. PubMed ID: 6702467 [TBL] [Abstract][Full Text] [Related]
12. A pharmacokinetic study of prednimustine as compared with prednisolone plus chlorambucil in cancer patients. Bastholt L; Johansson CJ; Pfeiffer P; Svensson L; Johansson SA; Gunnarsson PO; Mouridsen H Cancer Chemother Pharmacol; 1991; 28(3):205-10. PubMed ID: 1855277 [TBL] [Abstract][Full Text] [Related]
13. Studies on the pharmacokinetics of chlorambucil and prednimustine in man. Newell DR; Calvert AH; Harrap KR; McElwain TJ Br J Clin Pharmacol; 1983 Feb; 15(2):253-8. PubMed ID: 6849759 [TBL] [Abstract][Full Text] [Related]
14. Two novel nucleoside ester derivatives of chlorambucil as potential antileukemic prodrugs: a preliminary study. Kryczka T; Kazimierczuk Z; Kozłowska M; Chrapusta SJ; Vilpo L; Vilpo J; Stachnik K; Janisz M; Grieb P Anticancer Drugs; 2007 Mar; 18(3):301-10. PubMed ID: 17264763 [TBL] [Abstract][Full Text] [Related]
15. Long-term toxicology effects of prednimustine in comparison with chlorambucil, prednisolone, and chlorambucil plus prednisolone in Sprague-Dawley rats. Berger MR; Habs M; Schmähl D Semin Oncol; 1986 Mar; 13(1 Suppl 1):8-13. PubMed ID: 3952521 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of chlorambucil in man after administration of the free drug and its prednisolone ester (prednimustine, Leo 1031). Ehrsson H; Wallin I; Nilsson SO; Johansson B Eur J Clin Pharmacol; 1983; 24(2):251-3. PubMed ID: 6840176 [TBL] [Abstract][Full Text] [Related]
17. High-performance liquid chromatographic analysis of chlorambucil tert.-butyl ester and its active metabolites chlorambucil and phenylacetic mustard in plasma and tissue. Greig NH; Stahle PL; Shetty HU; Genka S; John V; Soncrant TT; Rapoport SI J Chromatogr; 1990 Dec; 534():279-86. PubMed ID: 2094719 [No Abstract] [Full Text] [Related]
18. Cholesterol ester formation by transesterification of chlorambucil: a novel pathway in drug metabolism. Gunnarsson PO; Johansson SA; Svensson L Xenobiotica; 1984 Jul; 14(7):569-74. PubMed ID: 6506771 [No Abstract] [Full Text] [Related]
19. Comparative carcinogenic activity of prednimustine, chlorambucil, prednisolone and chlorambucil plus prednisolone in Sprague-Dawley rats. Berger MR; Habs M; Schmähl D Arch Geschwulstforsch; 1985; 55(6):429-42. PubMed ID: 4083998 [TBL] [Abstract][Full Text] [Related]
20. Prednisolone plasma levels after oral administration of Prednimustine. Comparison with levels obtained after administration of an equimolar dose of prednisolone. Sayed A; Hove WV; Vermeulen A Oncology; 1981; 38(6):351-5. PubMed ID: 7301281 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]